Kassi Filkins, Editor

In this week's podcast episode with Maria Sampalis, OD, hear how to differentiate between branding and marketing.

The second pivotal phase 3 data on NOV03 (perfluorohexyloctane) show that NOV30 consistently met primary endpoints for signs and symptoms of dry eye disease associated with Meibomian gland dysfunction.

Catch up on what to expect from Lumenis.

A look back on what happened in optometry during the week of March 10-March 16.

Maria Sampalis, OD, shares first steps to get started in increasing net revenue in your practice.

Paul Chous, MA, OD, FAAO, shares key highlights from his 2023 SECO presentation looking at sleep disorders and how they play a role in eye disease.

A look back on what's happened in optometry during the week of March 3-March 9.

Continuing the conversation on practice management, Maria Sampalis, OD, shares tips on how to succeed in increasing revenue.

Andy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."

Nate Lighthizer, OD, gives highlights from his SECO 2023 presentation, "The glaucoma compass."

Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.

Contaminated Purely Soothing 15% MSM drops carry risk of eye infections that may result in vision loss. All consumers should stop use immediately.

Mile Brujic, OD, shares highlights from his SECO 2023 presentation, "Learning about the Lid: Optimizing recognition, diagnosis, and treatment of Demodex blepharitis and blepharoptosis."

This recall is being initiated out of an abundance of caution due to cracks that have developed in some of the units caps of brimonidine tartrate ophthalmic solution bottles

Mile Brujic, OD, shares highlights from his SECO 2023 poster presentation on confocal scanning laser imaging and patient care.

Chris Wroten, OD, shares key takeaways from his "Hot news or not news?" presentation at SECO 2023.

Nate Lighthizer, OD, shares what to expect from his SECO workshop, "Lasers in Optometry: The Next Frontier."

Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.

Mohammed Rafieetary, OD, shares key takeaways from his SECO 2023 presentation, "Advancing the understanding of geographic atrophy."

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."

Chris Wroten, OD, shares highlights from the hands-on laser workshop he co-led during SECO 2023.

A look back on what's happened in optometry during the week of February 25-March 2.

Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key takeaways from his SECO 2023 presentation, "Drugs of the future."

Shalu Pal, BSc, OD, FAAO, shares key takeaways from the contact lens zpanel discussion she participated in.

Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key highlights from his portion of the "Presbyopia management panel," during SECO 2023 in Atlanta.

Continuing the conversation on practice management, Maria Sampalis, OD, shares why increasing revenue is important for a sustainable optometric practice.

First 1-Day Lens that combines DigitalBoost and Aquaform technologies designed to deliver comfort for ‘always on’ digital lifestyles

See the results from our recent poll!

A look back on what's happened in optometry during the week of February 18-February 23.

In this episode of a practice management series, Maria Sampalis, OD, touches on digital platforms and the importance of utilizing them.